Huntington National Bank’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Huntington National Bank’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-82,000	Closed	-$1.03M	–	1851
2014 Q3	$1.03M	Hold	82,000	–	–	0.02%	512
2014 Q2	$1.28M	Hold	82,000	–	–	0.03%	511
2014 Q1	$1.08M	Buy	+82,000	New	+$1.28M	0.02%	570

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Huntington National Bank's OSIR Position: Q4 2014 in Review

Huntington National Bank sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2014, closing a stake of 82,000 shares — an estimated $1.03M sold.

Huntington National Bank first reported a position in OSIR in Q1 2014 and held it in 3 quarters. The position peaked at $1.28M in Q2 2014. 66 funds tracked by Wall St. Rank hold OSIR as of Q4 2014.

Huntington National Bank reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
Huntington National Bank sold 82,000 Osiris Therapeutics, Inc. Common Stock shares in Q4 2014, an estimated $1.03M.
Huntington National Bank first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
Huntington National Bank's Osiris Therapeutics, Inc. Common Stock position peaked at $1.28M in Q2 2014.
66 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2014.

Based on Huntington National Bank's 13F filing for Q4 2014, filed 12 Feb 2015.